Tag: Centers for Medicare and Medicaid Services

FDA Approves New Treatment for Early Alzheimer’s

The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.

As Covid Deaths Climb, Even Seniors Skip the Latest Booster

Nearly all Americans over 65 got their initial Covid vaccines. But that immunity is waning, and this time, the government is offering far less support for new shots.

Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug

The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.

Families Cheer, Some Doctors Worry as Nursing Homes Open Doors Wide to Visitors

The federal government recently lifted most visitation restrictions at nursing homes. But concerns linger that a full reopening could leave residents vulnerable to another coronavirus surge.